Additional Considerations for Referral:²

• CRT non-responder
• Physical activity limited or impaired QOL

Patient Profile

• NYHA Class IIIB or IV
• Heart failure hospitalization(s)
• Unresponsive to diruetics or neurohormonal agents
  
  

Additional Considerations

• Ejection Fraction < 35%¹
• Persistently high PA pressures⁵
• Elevated Pro-BNP or BNP³
• 6MWD < 300m⁴

Patient Workup

Evaluating a heart failure patient for advanced therapies requires the integration of clinical, imaging, hemodynamic, functional and biomarker data.

The following tests and patient information may be needed when referring a patient for advanced heart failure evaluation and LVAD therapy.³

• Physical examination
• Blood tests
• Chest x-rays
• Electrocardiogram (EKG or ECG)
• Echocardiography (abbreviated as "echo")
• Exercise stress test
• Radionuclide ventriculography or multiple-gated acquisition scanning (abbreviated as MUGA)
• Cardiac catheterization
• Magnetic resonance imaging (MRI)
• 6-Minute Walk Test⁴

Referring Patients for Evaluation

When you refer your advanced heart failure patients to a HeartMate LVAD implant center, you can reassure them that:

• They will undergo a complete and thorough evaluation to determine if they are a candidate for advanced therapies, including LVAD therapy.
• Both them and their caregivers will receive additional details of the surgery. They’ll also have the opportunity to ask questions about the procedure, recovery, and living with their HeartMate 3 LVAD.